
July to September 2022
| Drug Name | Government Contribution Dollars | Prescriptions |
|---|---|---|
| MOLNUPIRAVIR | $194,504,253 | 179,163 |
| AFLIBERCEPT | $142,409,961 | 119,046 |
| ELEXACAFTOR + TEZACAFTOR + IVACAFTOR (&) IVACAFTOR | $121,562,080 | 5,691 |
| PEMBROLIZUMAB | $112,507,761 | 13,338 |
| NIVOLUMAB | $98,128,875 | 12,854 |
| USTEKINUMAB | $81,073,751 | 11,284 |
| APIXABAN | $77,016,360 | 928,529 |
| ADALIMUMAB | $72,573,153 | 80,836 |
| DENOSUMAB | $65,087,456 | 258,099 |
| LENALIDOMIDE | $62,886,119 | 11,441 |
| DUPILUMAB | $55,726,903 | 32,619 |
| NIRMATRELVIR (&) RITONAVIR | $55,719,544 | 50,970 |
| Drug Name | Government Contribution Dollars | Prescriptions |
|---|---|---|
| ROSUVASTATIN | $28,981,081 | 4,092,773 |
| ATORVASTATIN | $24,212,522 | 3,088,087 |
| PANTOPRAZOLE | $20,115,070 | 2,588,951 |
| ESOMEPRAZOLE | $23,554,647 | 2,146,886 |
| PERINDOPRIL | $12,474,112 | 1,807,224 |
| AMOXICILLIN | $5,565,197 | 1,626,911 |
| ESCITALOPRAM | $6,651,441 | 1,531,168 |
| METFORMIN | $12,661,898 | 1,507,769 |
| SERTRALINE | $6,648,195 | 1,431,422 |
| CEFALEXIN | $6,213,081 | 1,249,491 |
| AMLODIPINE | $8,297,162 | 1,236,414 |
| TELMISARTAN | $7,578,985 | 1,143,744 |
| Contributor | Contribution Dollars |
|---|---|
| Australian Government | $4,265,966,552 |
| Patients | $841,862,246 |